Study to evaluate the effectiveness of Abroma augusta 30CH and Xanthoxylum fraxineum 30CH in reducing menstrual pain in women with primary dysmenorrhoea

INTERVENTION: Intervention1: Abroma augusta 30CH: 30CH potency, 4 pills orally for the first 3 days of each menstrual cycle for 6 consecutive cycles Intervention2: Xanthoxylum fraxineum 30CH: 30CH potency, 4 pills orally for the first 3 days of each menstrual cycle for 6 consecutive cycles Control Intervention1: NIL: NIL CONDITION: Health Condition 1: N944‐ Primary dysmenorrhea PRIMARY OUTCOME: Change in mean pain intensity measured by Visual Analogue Scale VAS during the first 48 hours of menstruation.Timepoint: Change in mean pain intensity measured by Visual Analogue Scale VAS during the first 48 hours of menstruation in each of the six consecutive menstrual cycles SECONDARY OUTCOME: Duration of pain hoursTimepoint: During the first 48 hours of menstruation in each of the si Xconsecutive menstrual cycles Impact on quality of life using questionnaire WaLIDD ScoreTimepoint: Change in pain intensity from baseline to end of si Xmenstrual cycles Safety and adverse eventsTimepoint: Throughout the si Xconsecutive menstrual cycles Use of rescue analgesicsTimepoint: During each of the si Xconsecutive menstrual cycles INCLUSION CRITERIA: 1.Females aged 18 to 30 years 2.Regular menstrual cycles 21 to 35 days 3.History of Primary Dysmenorrhoea foe at least 6 months 4.Baseline pain intensity 4 or more on the 10 VAS 5.Willingness to provide informed consent and comply with study protocol